Jane Street’s Legend Biotech LEGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.29M Buy
71,500
+46,000
+180% +$877K ﹤0.01% 5944
2025
Q4
$554K Sell
25,500
-13,600
-35% -$390K ﹤0.01% 7444
2025
Q3
$1.28M Buy
39,100
+10,300
+36% +$380K ﹤0.01% 5805
2025
Q2
$1.02M Sell
28,800
-18,400
-39% -$596K ﹤0.01% 5576
2025
Q1
$1.6M Buy
47,200
+15,100
+47% +$542K ﹤0.01% 4729
2024
Q4
$1.04M Buy
32,100
+25,300
+372% +$1.05M ﹤0.01% 5303
2024
Q3
$331K Sell
6,800
-19,600
-74% -$1.04M ﹤0.01% 7865
2024
Q2
$1.17M Sell
26,400
-47,200
-64% -$2.18M ﹤0.01% 5482
2024
Q1
$4.13M Buy
73,600
+5,100
+7% +$308K ﹤0.01% 2913
2023
Q4
$4.12M Buy
68,500
+6,500
+10% +$412K ﹤0.01% 3144
2023
Q3
$4.16M Buy
62,000
+46,100
+290% +$3.2M ﹤0.01% 2879
2023
Q2
$1.1M Sell
15,900
-16,300
-51% -$1.07M ﹤0.01% 5053
2023
Q1
$1.55M Sell
32,200
-22,000
-41% -$1.08M ﹤0.01% 4249
2022
Q4
$2.71M Sell
54,200
-14,400
-21% -$698K ﹤0.01% 3380
2022
Q3
$2.8M Buy
68,600
+13,200
+24% +$620K ﹤0.01% 3574
2022
Q2
$3.05M Buy
55,400
+15,900
+40% +$671K ﹤0.01% 3417
2022
Q1
$1.44M Buy
39,500
+9,000
+30% +$356K ﹤0.01% 5383
2021
Q4
$1.42M Buy
+30,500
New +$1.55M ﹤0.01% 5202
2021
Q3
Sell
-4,900
Closed -$201K 10371
2021
Q2
$201K Buy
+4,900
New +$167K ﹤0.01% 8816

Other funds holding LEGN

Jane Street's LEGN Position: Q1 2026 in Review

Jane Street sold out of Legend Biotech (LEGN) in Q1 2026, closing a stake of 238,123 shares — an estimated $4.54M sold.

Jane Street first reported a position in LEGN in Q2 2020 and held it in 20 quarters. The position peaked at $5.18M in Q4 2025. 190 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Jane Street reported no remaining Legend Biotech position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 238,123 Legend Biotech shares in Q1 2026, an estimated $4.54M.
  • Jane Street first reported a position in Legend Biotech in Q2 2020 and held it in 20 quarters.
  • Jane Street's Legend Biotech position peaked at $5.18M in Q4 2025.
  • 190 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.